Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-May-24 9:27 PM View:  | Viking Therapeutics, Inc. (VKTX) | 01-May-24 | Option Exercise | 281,425 | $6.18 | $1,740,580.00 | 81% 348.51K to 629.93K | |
| 02-May-24 9:27 PM View: | Viking Therapeutics, Inc. (VKTX) | 01-May-24 | Planned Option Sale | 281,425 | $78.66 | $22,136,500.00 | (45%) 629.93K to 348.51K | |
| 27-Mar-24 8:52 PM View: | Viking Therapeutics, Inc. (VKTX) | 27-Mar-24 | Grant | 31,667 | -- | -- | 9% 348.51K to 380.18K | |
| 27-Mar-24 8:52 PM View: | Viking Therapeutics, Inc. (VKTX) | 27-Mar-24 | Payment of Exercise | 16,610 | $83.34 | $1,384,280.00 | (4%) 380.18K to 363.56K | |
| 04-Mar-24 7:52 PM View: | Viking Therapeutics, Inc. (VKTX) | 01-Mar-24 | Grant | 31,667 | -- | -- | 9% 333.8K to 365.47K | |
| 04-Mar-24 7:52 PM View: | Viking Therapeutics, Inc. (VKTX) | 01-Mar-24 | Payment of Exercise | 16,958 | $85.22 | $1,445,160.00 | (5%) 365.47K to 348.51K | |
| 04-Jan-24 9:36 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-24 | Payment of Exercise | 14,199 | $18.58 | $263,817.00 | (4%) 348.0K to 333.8K | |
| 04-Jan-24 9:36 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-24 | Grant | 98,334 | -- | -- | 33% 298.87K to 397.21K | |
| 04-Jan-24 9:36 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-24 | Payment of Exercise | 49,210 | $17.40 | $856,254.00 | (12%) 397.21K to 348.0K | |
| 18-Apr-23 7:08 PM View: | Viking Therapeutics, Inc. (VKTX) | 17-Apr-23 | Option Exercise | 12,500 | $13.07 | $163,375.00 | 4% 287.76K to 300.26K | |
| 18-Apr-23 7:08 PM View: | Viking Therapeutics, Inc. (VKTX) | 17-Apr-23 | Planned Option Sale | 12,500 | $20.00 | $250,000.00 | (4%) 300.26K to 287.76K | |
| 03-Apr-23 7:22 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Mar-23 | Grant | 56,667 | -- | -- | 22% 261.89K to 318.56K | |
| 03-Apr-23 7:22 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Mar-23 | Payment of Exercise | 30,799 | $17.57 | $541,138.00 | (9%) 354.66K to 323.86K | |
| 03-Apr-23 7:22 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Mar-23 | Option Exercise | 36,100 | $8.12 | $293,122.00 | 11% 318.56K to 354.66K | |
| 03-Apr-23 7:22 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Mar-23 | Option Exercise | 36,100 | $17.01 | $614,028.00 | (11%) 323.86K to 287.76K | |
| 30-Mar-23 9:04 PM View: | Viking Therapeutics, Inc. (VKTX) | 29-Mar-23 | Option Exercise | 15,000 | $9.13 | $136,950.00 | 5% 288.14K to 303.14K | |
| 30-Mar-23 9:04 PM View: | Viking Therapeutics, Inc. (VKTX) | 29-Mar-23 | Sale (Planned) | 41,242 | $16.00 | $659,872.00 | (14%) 303.14K to 261.89K | |
| 30-Mar-23 9:04 PM View: | Viking Therapeutics, Inc. (VKTX) | 28-Mar-23 | Option Exercise | 167,427 | $2.37 | $397,193.00 | 53% 317.27K to 484.7K | |
| 30-Mar-23 9:04 PM View: | Viking Therapeutics, Inc. (VKTX) | 28-Mar-23 | Planned Option Sale | 182,427 | $15.00 | $2,736,400.00 | (38%) 484.7K to 302.27K | |
| 30-Mar-23 9:04 PM View: | Viking Therapeutics, Inc. (VKTX) | 28-Mar-23 | Sale (Planned) | 14,136 | $15.00 | $212,040.00 | (5%) 302.27K to 288.14K | |
| 17-Jan-23 7:39 PM View: | Viking Therapeutics, Inc. (VKTX) | 15-Jan-23 | Payment of Exercise | 1,079 | $8.95 | $9,657.05 | (< 1%) 318.35K to 317.27K | |
| 04-Jan-23 6:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-23 | Payment of Exercise | 13,994 | $8.42 | $117,829.00 | (4%) 332.35K to 318.35K | |
| 04-Jan-23 6:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-23 | Grant | 90,667 | -- | -- | 35% 260.53K to 351.2K | |
| 04-Jan-23 6:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-23 | Payment of Exercise | 18,854 | $8.52 | $160,636.00 | (5%) 351.2K to 332.35K | |
| 04-Jan-23 6:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Dec-22 | Grant | 23,500 | -- | -- | 9% 249.81K to 273.31K | |
| 04-Jan-23 6:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Dec-22 | Payment of Exercise | 12,773 | $9.40 | $120,066.00 | (5%) 273.31K to 260.53K | |
| 11-Feb-22 6:34 PM View: | Viking Therapeutics, Inc. (VKTX) | 15-Jan-22 | Payment of Exercise | 827 | $4.24 | $3,506.48 | (< 1%) 239.52K to 238.69K | (< 1%) |
| 05-Jan-22 7:12 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-22 | Payment of Exercise | 11,845 | $4.62 | $54,723.90 | (5%) 251.37K to 239.52K | |
| 05-Jan-22 7:12 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-22 | Grant | 77,333 | -- | -- | 43% 177.95K to 255.29K | |
| 05-Jan-22 7:12 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-22 | Payment of Exercise | 3,919 | $4.88 | $19,124.70 | (2%) 255.29K to 251.37K | |
| 30-Sep-21 5:45 PM View: | Viking Therapeutics, Inc. (VKTX) | 28-Sep-21 | Grant | 6,667 | -- | -- | 4% 173.71K to 180.37K | |
| 30-Sep-21 5:45 PM View: | Viking Therapeutics, Inc. (VKTX) | 28-Sep-21 | Payment of Exercise | 2,839 | $6.50 | $18,453.50 | (2%) 180.37K to 177.53K | |
| 19-Jan-21 6:23 PM View: | Viking Therapeutics, Inc. (VKTX) | 19-Jan-21 | Payment of Exercise | 994 | $6.68 | $6,639.92 | (< 1%) 170.95K to 169.95K | 3% |
| 19-Jan-21 6:23 PM View: | Viking Therapeutics, Inc. (VKTX) | 15-Jan-21 | Payment of Exercise | 686 | $6.48 | $4,445.28 | (< 1%) 171.63K to 170.95K | 0% |
| 06-Jan-21 4:26 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-21 | Grant | 79,750 | -- | -- | 84% 94.66K to 174.41K | |
| 06-Jan-21 4:26 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-21 | Payment of Exercise | 2,773 | $5.80 | $16,083.40 | (2%) 174.41K to 171.63K |